Global High Flow Nasal Cannula Industry to achieve US$ 17.7 Billion by 2030, propelled by an upswing in demand for respiratory care | FMI

Global High Flow Nasal Cannula Industry

The global high flow nasal cannula Industry has witnessed substantial growth in recent years, driven by a combination of technological advancements, increased prevalence of respiratory disorders, and a growing aging population. This medical device, which delivers a high flow of oxygen-enriched air to patients with respiratory issues, has revolutionized the way healthcare professionals manage respiratory conditions.

One of the key factors contributing to the expansion of the high flow nasal cannula industry is its effectiveness in treating various respiratory disorders, including chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), and bronchiolitis, among others. Unlike traditional oxygen therapy methods, such as masks or low-flow nasal cannulas, high-flow nasal cannulas offer several advantages. They deliver a precise and adjustable oxygen concentration while providing heated and humidified air, reducing the risk of dryness and discomfort for patients. This not only improves patient comfort but also enhances treatment compliance, ultimately leading to better clinical outcomes.

Request A Sample Copy of This Report! https://www.futuremarketinsights.com/reports/sample/rep-gb-11269

Sales of high-flow nasal cannulas are anticipated to increase between 2022 and 2030 at a CAGR of 11.6%. By 2030, the market for high flow nasal cannulas is expected to be valued US$ 17.7 billion, up from 7.37 billion in 2022.

Furthermore, the COVID-19 pandemic has spotlighted the importance of high-flow nasal cannulas in managing severe respiratory cases. These devices played a crucial role in providing non-invasive respiratory support to patients, especially those with COVID-19-induced respiratory distress. The pandemic accelerated the adoption of high-flow nasal cannulas in healthcare facilities worldwide, and this trend is expected to persist even as the pandemic subsides.

The high flow nasal cannula industry is also benefiting from ongoing research and development efforts. Manufacturers are continually innovating to enhance the performance and ease of use of these devices. They are also exploring new applications, such as the use of high-flow nasal cannulas in post-operative care and palliative care settings, further expanding the market’s potential.

Key factors driving the growth of the high flow nasal cannula industry included:

1. Increasing Prevalence of Respiratory Disorders: The rising prevalence of respiratory diseases such as COPD, asthma, and pneumonia has been a significant driver for the HFNC market. HFNC therapy is an effective way to manage these conditions.
2. Aging Population: With an aging population worldwide, there is a higher demand for respiratory care devices, including HFNCs. Older individuals are more susceptible to respiratory illnesses, which leads to an increased need for respiratory support.
3. Technological Advancements: Ongoing advancements in HFNC technology have improved the efficiency and effectiveness of these devices. This has led to increased adoption among healthcare providers.
4. COVID-19 Pandemic: The COVID-19 pandemic put additional pressure on healthcare systems globally, leading to a surge in the use of respiratory support devices, including HFNCs, for patients with severe respiratory symptoms.
5. Homecare Market: HFNCs are also being adopted for homecare settings to provide long-term respiratory support for patients with chronic conditions. This expansion into the homecare market has contributed to market growth.
6. Patient Comfort: HFNC therapy is generally well-tolerated by patients due to its high flow rates, humidification, and comfort compared to traditional oxygen therapy methods.

Feel Free To Reach Out To Our Analyst For Any Queries You Might Have! https://www.futuremarketinsights.com/ask-question/rep-gb-11269

Key Companies Profiled:

• CR BARD Inc.
• Fisher & Paykel Healthcare Limited
• Vapotherm Inc.
• Teleflex Incorporated
• Teijin Pharma Limited
• TNI Medical AG
• ResMed Corporation
• Smiths Medical
• MEK-ICS Co., Ltd.
• Hamilton Medical AG
• Flexicare Medical Limited (U. K.)

Key Segments of High Flow Nasal Cannula Industry Survey:

High Flow Nasal Cannula Industry by Component:

• Air/Oxygen Blenders
• Active Humidifiers
• Nasal Cannulas
• Heated Inspiratory Circuits
• Consumables

High Flow Nasal Cannula Industry by Medical Application:

• Acute Respiratory Failure
• Chronic Obstructive Pulmonary Disease (COPD)
• Bronchiectasis
• Carbon Monoxide Toxicity
• Sleep Apnea
• Acute Heart Failure

High Flow Nasal Cannula Industry by End User:

• Hospitals
• Specialty Clinics
• Long-term Care Centers
• Ambulatory Care Centers
• Homecare Settings

High Flow Nasal Cannula Industry by Region:

• North America high flow nasal cannula industry
• Latin America high flow nasal cannula industry
• Europe high flow nasal cannula industry
• East Asia high flow nasal cannula industry
• South Asia & Pacific high flow nasal cannula industry
• Middle East & Africa (MEA) high flow nasal cannula industry

Customize Your Knowledge: Unique Perspective and Actionable Insights Growth in the High Flow Nasal Cannula Industry! https://www.futuremarketinsights.com/customization-available/rep-gb-11269

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube